Angle PLC: Director's share purchase
(firmenpresse) - SURREY, UNITED KINGDOM -- (Marketwired) -- 10/27/16 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)
OTCQX: ANPCY
("ANGLE" or the "Company")
ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, announces that it was notified today that Andrew Newland, Chief Executive of ANGLE, has purchased 1,350,000 ordinary shares of 10p each in the Company ("Ordinary Shares"). These shares were purchased at a price of 57 pence per share in accordance with the sale and repurchase agreement (the "Agreement"), as described in the Company's announcement of 12 November 2014.
The Agreement has now terminated and Mr Newland's legal and beneficial interest in the Company reverts to the same level as it was prior to the Agreement, being 7,054,686 Ordinary Shares, now representing 9.43 per cent of the Company's issued share capital.
This announcement contains inside information.
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contacts:
RNS
Customer Services
0044-207797-4400
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.10.2016 - 06:00 Uhr
Sprache: Deutsch
News-ID 503088
Anzahl Zeichen: 0
contact information:
Town:
SURREY, UNITED KINGDOM
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 207 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Angle PLC: Director's share purchase"
steht unter der journalistisch-redaktionellen Verantwortung von
Angle PLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
